People Background Check
Find People:

Michelle Grace Stewart, Age 47174 Pine St, Danville, NH 03819

Get Report
Known as:
Michelle G Stewart David W Stewart David L Stewart Michelle G Giannotti David S Tewart Michelle Stewar Stewart David
Related to:
Gay A Urban 64

Michelle Stewart Phones & Addresses

Danville, NH

Merrimac, MA

Woburn, MA

Nashua, NH

Hudson, NH

Merrimack, NH

Chaparral, NM

Santa Fe, NM

Amherst, NH

Reading, MA

Show more

Work

Company: Jackpot provision co 2011 Position: Marketing support

Education

School / High School: Daniel Webster College- Nashua, NH 2007 Specialities: Associates in General Studies

Images

Mentions for Michelle Grace Stewart

Career records & work history

Real Estate Brokers

Michelle Stewart Photo 1

Michelle Stewart

Specialties:
Property Management

Lawyers & Attorneys

Michelle Stewart Photo 2

Michelle Stewart - Lawyer

Office:
Reed Smith LLP
Specialties:
Advertising, Securities / Investment Fraud, Advertising, Corporate & Securities, Corporate Governance, Emerging Growth / Venture Capital, Mergers & Acquisitions, Technology Transactions, Investment Management, Private Equity, Energy & Natural Resources, Infrastructure Projects, Power, Renewable & Clean Energy
ISLN:
922215859
Admitted:
2010
University:
Duke University, B.A., 2007; Duke University, B.A., 2007
Law School:
University of Chicago Law School, J.D., 2010
Michelle Stewart Photo 3

Michelle Stewart - Lawyer

ISLN:
1000384654
Admitted:
2017
Michelle Stewart Photo 4

Michelle Stewart - Lawyer

Office:
Fasken Martineau DuMoulin LLP
Specialties:
Real Estate
ISLN:
920781645
University:
Capilano College, 1999; Capilano College, 1999; MTC College, 1988; MTC College, 1988

Medicine Doctors

Michelle A. Stewart

Specialties:
Family Medicine
Work:
Maple Street Clinic
1825 Maple St, Forest Grove, OR 97116
(503) 357-2136 (phone) (503) 359-5479 (fax)
Site
Languages:
English, Spanish
Description:
Ms. Stewart works in Forest Grove, OR and specializes in Family Medicine. Ms. Stewart is affiliated with Tuality Community Hospital and Tuality Forest Grove Hospital.

Michelle Stewart resumes & CV records

Resumes

Michelle Stewart Photo 52

Michelle Stewart - Danville, NH

Work:
Jackpot Provision Co 2011 to 2000
Marketing Support Odyssey Systems Consulting Group Dec 2010 to 2000
Business Manager Odyssey Systems Consulting Group - Bedford, MA Sep 2009 to Dec 2010
Training Manager Odyssey Systems Consulting Group - Bedford, MA Nov 2008 to Sep 2009
Recruiter Odyssey Systems Consulting Group - Bedford, MA Aug 2006 to Nov 2008
Administrative Specialist JoAnn Fabrics and Crafts - Nashua, NH Aug 2003 to Aug 2006
Merchandise Manager Century Bank FSB - Santa Fe, NM 1998 to 2000
Customer Service Representative
Education:
Daniel Webster College - Nashua, NH 2007 to 2009
Associates in General Studies

Publications & IP owners

Us Patents

Inhibitors Of C-Met And Uses Thereof

US Patent:
7998987, Aug 16, 2011
Filed:
Apr 8, 2010
Appl. No.:
12/756301
Inventors:
David Lauffer - Stow MA, US
Alex Aronov - Newton MA, US
Pan Li - Lexington MA, US
David Deininger - Waltham MA, US
Kira McGinty - Schenectady NY, US
Dean Stamos - Carlsbad CA, US
Jon Come - Cambridge MA, US
Michelle Stewart - Brookline MA, US
Assignee:
Vertex Pharmaceuticals Incorporated - Cambridge MA
International Classification:
C07D 513/04
A61K 31/433
US Classification:
514363, 548126
Abstract:
The present invention provides compounds useful as inhibitors of c-Met tyrosine kinase. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various proliferative disorders.

Pyrrolopyridines Useful As Inhibitors Of Protein Kinase

US Patent:
2007013, Jun 14, 2007
Filed:
May 22, 2006
Appl. No.:
11/438748
Inventors:
Mark Ledeboer - Acton MA, US
Marion Wannamaker - Stow MA, US
Luc Farmer - Foxboro MA, US
Tiansheng Wang - Concord MA, US
Albert Pierce - Cambridge MA, US
Randy Bethiel - Lexington MA, US
Guy Bemis - Arlington MA, US
Jian Wang - Newton MA, US
Francesco Salituro - Marlboro MA, US
Michael Arnost - North Andover MA, US
Jon Come - Cambridge MA, US
Jeremy Green - Waltham MA, US
Michelle Stewart - Somerville MA, US
Craig Marhefka - Rockville MD, US
International Classification:
A61K 31/506
A61K 31/4745
C07D 471/02
US Classification:
514275000, 514300000, 546113000, 544324000
Abstract:
The present invention relates to compounds useful as inhibitors of protein kinases, particularly of JAK family and ROCK family kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

Inhibitors Of C-Met And Uses Thereof

US Patent:
2007019, Aug 16, 2007
Filed:
Nov 30, 2006
Appl. No.:
11/606524
Inventors:
David Lauffer - Stow MA, US
Alexander Aronov - Watertown MA, US
Pan Li - Lexington MA, US
David Deininger - Waltham MA, US
Kira McGinty - Medford MA, US
Dean Stamos - Carlsbad CA, US
Jon Come - Cambridge MA, US
Michelle Stewart - Cambridge MA, US
International Classification:
A61K 31/53
A61K 31/497
A61K 31/506
A61K 31/501
A61K 31/4439
A61K 31/433
C07D 498/04
US Classification:
514241000, 514252060, 514255050, 514256000, 514338000, 514362000, 514248000, 544209000, 544238000, 544331000, 544405000, 546269100, 546268700, 548125000
Abstract:
The present invention provides compounds useful as inhibitors of c-Met tyrosine kinase. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various proliferative disorders.

Pyrazolo[1,5-A]Pyrimidines Useful As Jak2 Inhibitors

US Patent:
2011011, May 19, 2011
Filed:
Jun 17, 2010
Appl. No.:
12/817785
Inventors:
Mark LEDEBOER - Acton MA, US
Valerie MARONE - Somerville MA, US
Michelle STEWART - Brookline MA, US
David MESSERSMITH - Somerville MA, US
John DUFFY - Northborough MA, US
Gabriel MARTINEZ BOTELLA - Wayland MA, US
Jon COME - Cambridge MA, US
Huai GAO - Arlington MA, US
Albert PIERCE - Cambridge MA, US
Francesco SALITURO - Marlborough MA, US
Assignee:
VERTEX PHARMACEUTICALS INCORPORATED - Cambridge MA
International Classification:
A61K 31/519
C07D 487/04
A61K 31/5377
A61P 35/04
C12N 9/99
US Classification:
5142332, 544117, 544281, 5142593, 435184
Abstract:
The present invention relates to compounds of formula (I) useful as selective inhibitors of JAK2 kinase. The invention also provides pharmaceutical acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various diseases, conditions or disorders. The invention also provides processes for preparing the compounds of the invention.

Methods And Compositions For Specific Modulation Of Mcl-1

US Patent:
2012017, Jul 5, 2012
Filed:
Dec 9, 2009
Appl. No.:
13/133883
Inventors:
Loren D. Walensky - Newton MA, US
Michelle L. Stewart - Brookline MA, US
International Classification:
A61K 38/17
C07K 14/435
C07K 7/08
A61P 35/00
A61P 31/00
A61K 38/10
A61K 38/08
A61P 35/02
A61P 37/00
A61P 29/00
A61P 31/06
A61P 31/14
A61P 19/02
A61P 1/00
A61P 19/04
A61P 31/04
C12N 5/071
C12Q 1/02
G01N 33/566
G01N 21/64
G01N 21/78
C12Q 1/18
C07K 7/06
US Classification:
514 14, 530328, 530326, 530327, 530325, 530324, 514 122, 514 193, 514 23, 514 213, 514 214, 514 215, 514 216, 514 217, 514 196, 514 166, 514 24, 514 37, 514 167, 514 194, 514 28, 435375, 435 29, 436501, 435 792, 435 32
Abstract:
A series of stapled BCL-2 family peptide helices were identified as able to target the survival protein MCL-I with high affinity and a subset with unprecedented selectivity. Agents and methods for selective pharmacologic neutralization of MCL-I are provided for drug discovery and therapeutic uses, including use in overcoming the apoptotic resistance of cancer and other diseases associated with impaired cell death.

Small Molecules For The Modulation Of Mcl-1 And Methods Of Modulating Cell Death, Cell Division, Cell Differentiation And Methods Of Treating Disorders

US Patent:
2013003, Feb 7, 2013
Filed:
Jan 31, 2011
Appl. No.:
13/576116
Inventors:
Loren D. Walensky - Newton Centre MA, US
Michelle L. Stewart - Brookline MA, US
Nicole Cohen - Newton MA, US
International Classification:
A61K 31/7034
C07D 311/30
A61K 31/352
A61P 35/00
C07C 255/42
A61K 31/26
C07D 407/04
A61K 31/351
C07J 43/00
A61K 31/58
C07D 493/04
A61K 31/366
C07C 321/30
A61K 31/10
C07C 39/16
A61K 31/055
C07H 15/203
C07D 405/14
A61K 31/498
A61K 31/53
C07D 409/12
A61K 31/5415
C07D 279/06
A61K 31/54
C07D 409/14
A61K 31/55
C12N 5/071
US Classification:
514 35, 435375, 549400, 514456, 558401, 514514, 549313, 514460, 540106, 514176, 549278, 514453, 568 48, 514712, 568726, 514735, 536 182, 544353, 514249, 544182, 514242, 544 39, 5142258, 544 54, 5142272, 540603, 5142171
Abstract:
This invention relates to compounds which selectively bind to the survival protein MCL-1 with high affinity and selectivity, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for modulating MCL-1 activity and for treating hyperproliferative disorders, angiogenesis disorders, cell cycle regulation disorders, autophagy regulation disorders, inflammatory disorders, and/or infectious disorders and/or for enhancing cellular engraftment and/or wound repair, as a sole agent or in combination with other active ingredients.

Bh4 Stabilized Peptides And Uses Thereof

US Patent:
2019009, Mar 28, 2019
Filed:
Aug 31, 2018
Appl. No.:
16/119974
Inventors:
- Boston MA, US
Michelle L. Stewart - Cambridge MA, US
Lauren Barclay - Brookline MA, US
International Classification:
C07K 14/47
A61K 49/00
A61K 45/06
A61K 38/17
G01N 33/68
A61K 9/08
A61K 9/00
A61K 38/00
Abstract:
Provided herein are polypeptides containing stabilized BH4 domains of BCL-2 family proteins that are capable of binding and/or inactivating and/or modulating BAX protein, and/or its close homologues BAK and BOK, and/or other physiological BH4 targets. Also provided are compositions containing these polypeptides and methods of treating cytotoxic diseases that include administering to a subject one of the polypeptides.

Small Molecules For The Modulation Of Mcl-1 And Methods Of Modulating Cell Death, Cell Division, Cell Differentiation And Methods Of Treating Disorders

US Patent:
2018026, Sep 20, 2018
Filed:
May 1, 2018
Appl. No.:
15/968384
Inventors:
- Boston MA, US
Michelle L. Stewart - Cambridge MA, US
Nicole Cohen - Newton MA, US
International Classification:
C07D 513/04
C07D 417/04
C07D 403/08
C07D 409/14
C07D 409/06
C07D 405/14
C07D 409/12
C07D 279/06
C07D 413/06
C07D 401/12
C07D 277/34
C07D 403/06
C07D 307/54
C07D 249/12
C07D 413/14
C07D 405/12
C07D 327/04
C07D 239/60
C07C 311/20
C07C 337/08
C07C 251/84
C07C 335/16
C07C 251/20
C07D 403/04
C07D 417/14
Abstract:
This invention relates to compounds which selectively bind to the survival protein MCL-1 with high affinity and selectivity, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for modulating MCL-1 activity and for treating hyperproliferative disorders, angiogenesis disorders, cell cycle regulation disorders, autophagy regulation disorders, inflammatory disorders, and/or infectious disorders and/or for enhancing cellular engraftment and/or wound repair, as a sole agent or in combination with other active ingredients.

Possible Relatives

Cyrus Stewart  Dayna Stewart  Dean Stewart  Daisy C Stewart  Deanne E Stewart  Dallas L Stewart  Dalton H Stewart  Michelle R Stamps  Michelle M Standifer  Michelle C Standridge 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.